HHS herein publishes the panels of Schedule I and II drugs and biomarkers authorized for testing in federal workplace drug testing programs. The Department has made no revisions to the current drug testing panels for both urine and oral fluid and current required nomenclature for laboratory and Medical Review Officer Reports, effective July 7, 2025.

Published

Mar 13, 2026

Citation

91 FR 12308

Agencies

2026-04981Mandatory Guidelines for Federal Workplace Drug Testing Programs-Authorized Testing Panels

Federal Register →PDF

Full text not available in our database.

View on Federal Register →

AI Summary

Get a plain-English explanation of what this regulation does, which agencies are responsible, and how it affects existing rules.

No document text available yet

Agencies (1)

HHS — Health and Human Services Department

CFR References

42 CFR

Document Details

Type: Final Rule
Action: Issuance of authorized drug testing panels.
Document #: 2026-04981
Citation: 91 FR 12308
Publication Date: Mar 13, 2026
Dates: The current authorized drug testing panels and required report nomenclature remain in effect.
Federal Register Pages: Vol. 91, pp. 12308–12311
Page Views: 0

Source Links

Federal Register (HTML)Federal Register (PDF)

←

Proposed: Fisheries of the Northeastern Unite…

Rule: Airworthiness Directives; The Boein…

→